Episodios

  • Guideline-Driven Strategies in MS: De-escalating and Discontinuing Disease-Modifying Therapies
    Sep 4 2025
    In this episode, Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, discusses the first comprehensive recommendations for de-escalating and discontinuing disease-modifying therapies in select individuals living with multiple sclerosis developed by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
    Más Menos
    13 m
  • New Guidelines for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Rethinking Hematopoietic Stem Cell Transplantation
    Aug 25 2025
    Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, reviews the latest international guidelines from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and EBMT on the use of autologous hematopoietic stem cell transplantation (AHSCT) in relapsing multiple sclerosis and neuromyelitis optica spectrum disorder.
    Más Menos
    12 m
  • The Optic Nerve in Multiple Sclerosis
    Feb 26 2025
    Peter Sguigna, MD, Assistant Professor, UT Southwestern, Dallas, TX, discusses recent updates related to the optic nerve in the 2024 McDonald diagnostic criteria for multiple sclerosis (MS) along with the importance of considering neuro-ophthalmology findings when caring for patients with MS.
    Más Menos
    11 m
  • Subcutanous Ocrevus Zunovo as a New Treatment Option for Multiple Sclerosis
    Dec 11 2024
    In this episode, Scott D. Newsome, DO, Professor of Neurology, Johns Hopkins University, Baltimore, MD, discusses how Ocrevus Zunovo can be used to treat primary progressive and relapsing forms of multiple sclerosis, including how the drug is administered, research related to the efficacy of this formulation, and the impact on clinical practice and patients.
    Más Menos
    15 m
  • 2024 McDonald Diagnostic Criteria for Multiple Sclerosis
    Nov 20 2024
    Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, provides an overview of the 2024 McDonald diagnostic criteria for multiple sclerosis including what's changed, the rationale for updates, and next steps in implementing the recommendations.
    Más Menos
    10 m
  • 10-year Study Data Shows Reduced Disability in MS Patients Treated with Ocrevus
    Jul 15 2024
    Robert Bermel, MD, Director of the Mellen Center for Multiple Sclerosis,Cleveland Clinic, provides an overview of the 10-year study data demonstrating Ocrevus treatment reduces disability in participants with MS.
    Más Menos
    11 m
  • MS Masters Toolbox: Cramps, Spasms, and Spasticity
    Sep 22 2023
    In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 4 provides tools for cramps, spasms, and spasticity. Increasing prevalence of spasticity is closely associated with increasing disease duration, progressive disease and disability in Multiple Sclerosis.
    Más Menos
    19 m
  • MS Masters Toolbox: Balance, Gait and Mobility
    Aug 19 2022
    In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 3 provides tools for balance, gait and mobility, one of the most challenging aspects of MS.
    Más Menos
    19 m
adbl_web_global_use_to_activate_DT_webcro_1694_expandible_banner_T1